(ANSA) - MILAN, MAY 11 - Mortality of patients treated with hyperimmune plasma has fallen from 15% to 6%: this is the result of the experimentation conducted by the Policlinico SanMatteo di Pavia with the Asst of Mantua and presented today by the Lombardy Region conducted on 46 patients. "In the beginning, the mortality rate in patients in assisted ventilation admitted to intensive care was between 13 and 20%, about 15% on average, while with hyperimmune plasma treatment it fell to 6%", explained Fausto Baldanti, director of virology joint unit of SanMatteo di Pavia.
"This morning I had an interview with Minister Speranz, who confirmed to me that the government has no particular interest in pursuing this initiative": so the president of Lombardy Attilio Fontana commented on the result of the experimentation of the treatment.
With cure plasma mortality reduced to 6%
2020-05-11T18:09:05.577Z
The mortality rate of patients treated with hyperimmune plasma has fallen from 15% to 6%: this is the result of the experimentation conducted by the Policlinico San Matteo di Pavia with the Asst of Mantua and presented today by the Lombardy Region conducted on 46 patients. (HANDLE)
